{"anticipatedPostingDate":"2031-06","denomUnitsSelected":"Participants","description":"Determine if MRD levels and tumor markers (soluble cluster of Differentiation 25 (CD25) and cluster of differentiation-22 (CD22), and real-time quantitative reverse transcriptase polymerase chain reaction (RQ-PCR) correlate with response and clinical endpoints, and if bone marrow magnetic resonance imaging (MRI) signal correlates with bone marrow biopsy (BMBx) results, and whether these tests could in some cases possibly replace BMBx.","reportingStatus":"NOT_POSTED","timeFrame":"4 years","title":"Correlation of Measurable Residual Disease (MRD) Levels and Tumor Markers With Response","type":"SECONDARY"}